These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4828842)

  • 1. Inhibition of alpha-chymotrypsin by hydroxymethyl analogues of D-and L-N-acetylphenylalanine and N-acetyltryptophan of potential affinity labeling value.
    Jones JB; Sneddon DW; Lewis AJ
    Biochim Biophys Acta; 1974 Mar; 341(1):184-90. PubMed ID: 4828842
    [No Abstract]   [Full Text] [Related]  

  • 2. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational change associated with the acylation of alpha-chymotrypsin by N-acetyl-L-phenylalanine methyl ester.
    Fink AL; Wildi E
    J Biol Chem; 1974 Oct; 249(19):6087-9. PubMed ID: 4371428
    [No Abstract]   [Full Text] [Related]  

  • 4. -Chymotrypsin: what can we learn about catalysis from x-ray diffraction?
    Henderson R; Wright CS; Hess GP; Blow DM
    Cold Spring Harb Symp Quant Biol; 1972; 36():63-70. PubMed ID: 4508173
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic analogues of the proteinase inhibitor: chymostatin.
    Galpin IJ; Wilby AH; Place GA; Beynon RJ
    Int J Pept Protein Res; 1984 May; 23(5):477-86. PubMed ID: 6735588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of chymostatin, a chymotrypsin inhibitor.
    Tatsuta K; Mikami N; Fujimoto K; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1973 Nov; 26(11):625-46. PubMed ID: 4792111
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of boronic acids to chymotrypsin.
    Rawn JD; Lienhard GE
    Biochemistry; 1974 Jul; 13(15):3124-30. PubMed ID: 4858346
    [No Abstract]   [Full Text] [Related]  

  • 8. Delta 9-tetrahydrocannabinol-protein conjugates.
    Tsui PT; Kelly KA; Ponpipom MM; Strahilevitz M; Sehon AH
    Can J Biochem; 1974 Mar; 52(3):252-8. PubMed ID: 4133412
    [No Abstract]   [Full Text] [Related]  

  • 9. 24Epsilon-methylcholestane-3beta,5alpha,6beta,25-tetrol 25-monoacetate. A novel polyhydroxylated steroid from an alcyonarian.
    Moldowan JM; Tursch BM; Djerassi C
    Steroids; 1974 Sep; 24(3):387-98. PubMed ID: 4153538
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificities of alpha-chymotrypsin and subtilisin Carlsberg. The alpha-acylamido effect in beta-phenylpropionates and their rigid analogs.
    Matta MS; Staley DD
    J Biol Chem; 1974 Feb; 249(3):732-7. PubMed ID: 4811900
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereochemistry of ammonia elimination from L-tyrosine with L-phenylalanine ammonia-lyase.
    Sawada S; Kumagai H; Yamada H; Hill RK; Mugibayashi Y; Ogata K
    Biochim Biophys Acta; 1973 Jul; 315(1):204-7. PubMed ID: 4795528
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear magnetic resonance studies of the interaction of N-acetyltryptophan with -chymotrypsin.
    Gerig JT; Rimerman RA
    J Am Chem Soc; 1972 Oct; 94(21):7565-9. PubMed ID: 5072870
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for hemiacetal formation between N-acyl-L-phenylalaninals and alpha-chymotrypsin by cross-saturation nuclear magnetic resonance spectroscopy.
    Chen R; Gorenstein DG; Kennedy WP; Lowe G; Nurse D; Schultz RM
    Biochemistry; 1979 Mar; 18(5):921-6. PubMed ID: 420824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of alpha-chymotrypsin by D-tryptophan amide covalently bound to macromolecular carriers: specific, steric, and electrostatic effects.
    Blumberg S; Katchalski-Katzir E
    Biochemistry; 1979 May; 18(10):2126-33. PubMed ID: 435472
    [No Abstract]   [Full Text] [Related]  

  • 15. Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions.
    Sakamoto H; Shimohigashi Y; Maeda I; Nose T; Nakashima K; Nakamura I; Ogawa T; Kawano K; Ohno M
    J Mol Recognit; 1993 Jun; 6(2):95-100. PubMed ID: 8305253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton and fluorine nuclear magnetic resonance spectroscopic observation of hemiacetal formation between N-acyl-p-fluorophenylalaninals and alpha-chymotrypsin.
    Gorenstein DG; Shah DO
    Biochemistry; 1982 Sep; 21(19):4679-86. PubMed ID: 7138821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic interaction of small molecules with alpha-chymotrypsin.
    Smith RN; Hansch C
    Biochemistry; 1973 Nov; 12(24):4924-37. PubMed ID: 4761974
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity-determining site of alpha-chymotrypsin. 3. Inactivation of alpha-chymotrypsin by p-diazo-N-acetyl-L-phenylalanine methyl ester.
    Yoshida N; Yamasaki M; Ishii S
    J Biochem; 1973 Jun; 73(6):1175-83. PubMed ID: 4724294
    [No Abstract]   [Full Text] [Related]  

  • 19. Leaving group specificity in the chymotrypsin-catalyzed hydrolysis of peptides. A stereochemical interpretation.
    Fersht AR; Blow DM; Fastrez J
    Biochemistry; 1973 May; 12(11):2035-41. PubMed ID: 4735878
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance studies of protein-small molecule interactions. Binding of N-trifluoroacetyl-D-(and L-)-tryptophan to -chymotrypsin.
    Smallcombe SH; Gammon KL; Richards JH
    J Am Chem Soc; 1972 Jun; 94(13):4581-4. PubMed ID: 5036167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.